| Malaisie | Turquie | Espagne | |
| Énucléation de l'oeil | de $3,200 | de $5,400 | de $8,500 |
| Une greffe de moelle osseuse | de $38,000 | de $36,000 | de $71,782 |
| Transplantation allogénique de moelle osseuse provenant d'un donneur non apparenté | de $85,000 | de $71,500 | de $150,000 |
| Transplantation allogénique de moelle osseuse d'un donneur apparenté | de $45,000 | de $53,500 | de $13,709 |
| Traitement complexe du sarcome d'Ewing | de $45,000 | de $30,000 | de $35,000 |
Bookimed ne rajoute pas de frais pour les traitements de Oncologie pédiatrique. Les tarifs proviennent des listes de prix officielles des cliniques. Vous payez directement à la clinique pour votre traitement à votre arrivée dans le pays.
Bookimed s'engage pour votre sécurité. Nous ne travaillons qu'avec des établissements médicaux qui respectent des normes internationales élevées dans le traitement de Oncologie pédiatrique et qui possèdent les licences nécessaires pour accueillir des patients internationaux dans le monde entier.
Bookimed offre une assistance experte gratuite. Un coordinateur médical personnel vous accompagne avant, pendant et après votre traitement, en résolvant tous les problèmes. Vous n'êtes jamais seul dans votre parcours de traitement de Oncologie pédiatrique.
Malaysia provides evidence-based paediatric oncology treatments including intensive chemotherapy, surgical resection, and radiotherapy. Specialist centres apply international protocols for leukaemia and solid tumours. Facilities offer high-tech interventions such as CyberKnife, Gamma Knife, and haematopoietic stem cell transplantation for complex paediatric cases.
Bookimed Expert Insight: While Malaysia offers high-level care, the country faces a specialist shortage with one oncologist for every 277 patients. This ratio often leads to longer wait times in government facilities. Choosing private centres in cities like George Town or Selangor can speed up the start of treatment.
Patient Consensus: Families note that Malaysian hospitals strictly follow global curative protocols for conditions like leukaemia. They suggest checking wait times for specialists and prioritising standard medical treatments over herbal alternatives to get the best possible outcomes in Malaysia.
Malaysia has specialised paediatric haemato-oncologists who treat childhood leukaemia and solid tumours. These experts work in multidisciplinary teams at major private hospitals. Specialists such as Dr Chan Lee Lee work at Subang Jaya Medical Centre (SJMC). They focus on paediatric cancer diagnosis and complex therapies.
Bookimed Expert Insight: While Malaysia has skilled specialists, paediatric oncology care is highly concentrated in private hubs. Subang Jaya Medical Centre (SJMC) stands out because it integrates paediatric-specific neurosurgery with oncology. This is vital for solid tumours like brain cancers. For these cancers, adult surgical teams may lack paediatric-specific precision.
Patient Consensus: Patients note that expert oncologists exist. However, they are mostly found in private hospitals in cities like Selangor and Penang. Families appreciate the multidisciplinary approach in Malaysia. However, they often travel to these specific private centres. They do this to avoid long wait times in public hospitals.
Paediatric cancer treatment in Malaysia typically spans 6 months to 3 years. Short-term intensive protocols for Acute Myeloid Leukaemia last about 6 months. Common cases like Acute Lymphoblastic Leukaemia require 1–3 years of care. While inpatient induction is mandatory, subsequent phases often proceed as outpatient services.
Bookimed Expert Insight: Malaysian private hospitals often use internationally recognised protocols like UKALL or BFM for leukaemia patients. These centres frequently bundle diagnostic tests like tumour marker blood tests and biochemical analysis. This streamlines the move to outpatient care. Families often find private care faster than public options for critical imaging like MRI.
Patient Consensus: Parents note that private hospitals in Malaysia provide much faster access to specialist care. Many prefer private settings to avoid long diagnostic waits. They also highlight that initial induction is always inpatient. However, the transition to day-care treatment is generally smooth for many leukaemia cases.
Malaysian specialist centres provide second opinions for paediatric oncology to confirm diagnoses and treatment plans. This is a standard practice for childhood cancers like leukaemia and lymphoma. Specialists at tertiary hospitals review pathology slides, imaging, and lab results. They verify the initial findings.
Bookimed Expert Insight: Malaysian medical hubs such as Selangor and George Town offer high-density specialist care. They are near transport links. Choosing a centre in these hubs simplifies logistics when transferring medical records between experts. Seeking a second opinion early helps the treatment protocol stay aligned with the latest research protocols.
Patient Consensus: Parents note that Malaysian specialists expect second opinion requests. These are part of standard care. They emphasise bringing full imaging and protocol details to avoid any evaluation delays.
Families of children with cancer in Malaysia access support through NGOs and private medical centres. Services include halfway homes for accommodation, psychosocial counselling, and financial guidance. Major hospitals provide rehabilitation like nutritional therapy and physiotherapy. This aids paediatric recovery during intensive treatments like chemotherapy.
Bookimed Expert Insight: Malaysia has a highly developed infrastructure for international patients. Centres like Sunfert International Fertility Centre are located in major medical hubs. These hubs often feature high-density clinics that share logistical support systems for families. This includes nearby serviced apartments designed for long-term clinical stays during paediatric care.
Patient Consensus: Parents in Malaysia often find the local support groups invaluable. These groups help navigate the unique logistical challenges of paediatric oncology. They note that access to halfway houses makes a significant difference. This is especially true during long hospital stays.
Paediatric cancer treatment in Malaysia lasts between 6 months and 3 years. For solid tumours, it takes 6 months; for leukaemia, up to 3 years. Intensive chemotherapy requires initial hospital stays of 2 to 4 weeks. Maintenance phases often transition to outpatient care using day care units and vascular access ports.
Bookimed Expert Insight: Malaysian medical hubs like Selangor and Penang provide strong infrastructure for international families. Public centres remain centralised. However, choosing a computerised tertiary facility in these regions often streamlines diagnostic timelines. This reduces the time spent waiting for blood count results between intensive chemotherapy cycles.
Patient Consensus: Parents note that initial intensive phases require roughly 120 days in hospital. After this, patients move to outpatient care. They emphasise that computerised facilities in Malaysia lead to better outcomes. These facilities also provide faster supportive services.
Top hospitals for paediatric cancer in Malaysia include Sunway Medical Centre, Gleneagles Hospital Medini Johor, and Beacon Hospital. These private facilities specialise in intensive treatments like chemotherapy and radiotherapy. They feature dedicated child-focused oncology units. They also have diagnostic equipment like PET-CT and Nuclear Medicine Units for precise tumour tracking.
Bookimed Expert Insight: Malaysian private hospitals often group oncology services together. Australian families should select centres with a dedicated paediatric intensivist and on-site paediatric surgery teams. This provides immediate specialised support if complications arise during intensive chemotherapy or tumour removal.
Patient Consensus: Parents in Malaysia emphasise verifying that hospitals have separate paediatric wards, not shared oncology floors. They note that the multidisciplinary teams in Johor and Kuala Lumpur provide excellent support. This helps families navigate complex recovery timelines.
Malaysia provides holistic support for paediatric oncology through public hospitals and non-profit organisations. Families access temporary accommodation, financial aid, and psychosocial counselling. Facilities like Hospital Kuala Lumpur offer specialist care. Support groups and charitable foundations help manage the emotional and logistical burden of childhood cancer.
Bookimed Expert Insight: Requesting a hospital social worker immediately upon admission is the most effective move. These specialists navigate specific local charity grants and transport support. Major hubs like Selangor or George Town have established infrastructure for international families. This early coordination helps bypass typical administrative delays for essential support services.
Patient Consensus: Families note hospital social workers are vital for finding local charity resources. Malaysian patients often share that early requests for help lead to better access. This includes transport and accommodation support.